Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation
暂无分享,去创建一个
T. Robbins | R. Cools | P. Pollak | B. Debu | P. Krack | S. Chabardès | V. Fraix | C. Ardouin | A. Castrioto | E. Lhommée | A. Funkiewiez | B. Debû
[1] Paul Krack,et al. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. , 2013, Brain : a journal of neurology.
[2] J. Régis,et al. Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[3] J. Kulisevsky,et al. Apathy in Parkinson's Disease: More Than Just Executive Dysfunction , 2013, Journal of the International Neuropsychological Society.
[4] P. Pollak,et al. Psychostimulant effect of levodopa: reversing sensitisation is possible , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[5] Eric Seigneuret,et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. , 2012, Brain : a journal of neurology.
[6] U. Bonuccelli,et al. Iowa gambling task in de novo Parkinson's disease: A comparison between good and poor performers , 2012, Movement disorders : official journal of the Movement Disorder Society.
[7] Michael S. Okun,et al. Effects of STN and GPi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation Syndrome , 2012, PloS one.
[8] A. Lang,et al. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. , 2011, Archives of neurology.
[9] A. Lang,et al. Impulse control disorders in parkinson disease: A multicenter case–control study , 2011, Annals of neurology.
[10] Y. Shimo,et al. Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson's disease. , 2011, Parkinsonism & related disorders.
[11] C. Winstanley,et al. Lesions of the Basolateral Amygdala and Orbitofrontal Cortex Differentially Affect Acquisition and Performance of a Rodent Gambling Task , 2011, The Journal of Neuroscience.
[12] N. Volkow,et al. Neurocircuitry of Addiction , 2010, Neuropsychopharmacology.
[13] P. Calabresi,et al. Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap , 2010, The Lancet Neurology.
[14] S. Houle,et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD , 2010, Neurology.
[15] U. Bonuccelli,et al. Decision making in de novo Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[16] L. Tremblay,et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. , 2010, Brain : a journal of neurology.
[17] M. Merello,et al. Decision‐making in Parkinson’s disease patients with and without pathological gambling , 2010, European journal of neurology.
[18] A. Lawrence,et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson’s disease , 2009, Journal of Clinical Neuroscience.
[19] E. Tolosa,et al. Neuroanatomical correlates of impaired decision‐making and facial emotion recognition in early Parkinson’s disease , 2009, The European journal of neuroscience.
[20] M. Delazer,et al. Decision making under risk and under ambiguity in Parkinson's disease , 2009, Neuropsychologia.
[21] T. Robbins,et al. Review Personality, Addiction, Dopamine: Insights from Parkinson's Disease Table 1. Possible Site of Striatal Dopamine Dysfunction Causing Different Motor and Cognitive Symptoms in Parkinson's Disease , 2022 .
[22] A. Strafella,et al. Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: A Trigger for Pathological Gambling in Parkinson's Disease? , 2009, Neuropsychopharmacology.
[23] A. Antonini,et al. Functional abnormalities underlying pathological gambling in Parkinson disease. , 2008, Archives of neurology.
[24] T. Robbins,et al. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making , 2008, Brain : a journal of neurology.
[25] Masaru Mimura,et al. Decision making in Parkinson's disease: Analysis of behavioral and physiological patterns in the Iowa gambling task , 2008, Movement disorders : official journal of the Movement Disorder Society.
[26] J. Kulisevsky,et al. Controlled study of decision‐making and cognitive impairment in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[27] M. D’Esposito,et al. Reversal learning in Parkinson's disease depends on medication status and outcome valence , 2006, Neuropsychologia.
[28] Yen F. Tai,et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission , 2006, Annals of neurology.
[29] M. Mimura,et al. Impaired decision-making in Parkinson's disease. , 2006, Parkinsonism & related disorders.
[30] A. Bechara. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective , 2005, Nature Neuroscience.
[31] Y. Agid,et al. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson’s disease? , 2005, Journal of Neurology Neurosurgery & Psychiatry.
[32] C. Tanner,et al. Levodopa and the progression of Parkinson's disease. , 2004, The New England journal of medicine.
[33] A. Benabid,et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 2003, The New England journal of medicine.
[34] R. Hilker,et al. Activation of basal ganglia loops in idiopathic Parkinson’s disease: a PET study , 2003, Journal of Neural Transmission.
[35] Laura Bellodi,et al. Decision-making heterogeneity in obsessive-compulsive disorder: ventromedial prefrontal cortex function predicts different treatment outcomes , 2002, Neuropsychologia.
[36] B. Dubois,et al. Motivation, reward, and Parkinson’s disease: influence of dopatherapy , 2002, Neuropsychologia.
[37] Roberto Keller,et al. Frontal lobe dysfunction in pathological gambling patients , 2002, Biological Psychiatry.
[38] T. Robbins,et al. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. , 2001, Cerebral cortex.
[39] T. Robbins,et al. Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication , 2000, Neuropsychologia.
[40] Y. Agid,et al. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible? , 2000, Annals of neurology.
[41] A. Damasio,et al. Insensitivity to future consequences following damage to human prefrontal cortex , 1994, Cognition.
[42] S. Kish,et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.